Limits...
Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis.

Ni Y, Shi G, Yu Y, Hao J, Chen T, Song H - Int J Chron Obstruct Pulmon Dis (2015)

Bottom Line: Six observational studies with 881 patients were included in the meta-analysis.Coexistence of bronchiectasis and COPD occurred more often in male patients with longer smoking history.Patients with COPD and comorbid bronchiectasis had greater daily sputum production, more frequent exacerbation, poorer lung function, higher level of inflammatory biomarkers, more chronic colonization by PPMs, and higher rate of Pseudomonas aeruginosa isolation.

View Article: PubMed Central - PubMed

Affiliation: Department of Pulmonary Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

ABSTRACT

Background: In the 2014 Global initiative for chronic Obstructive Lung Disease guidelines, bronchiectasis was for the first time defined as a comorbidity of chronic obstructive pulmonary disease (COPD), and this change has been retained in the 2015 update, which emphasizes the influence of bronchiectasis in the natural history of COPD. The present meta-analysis was aimed at summarizing the impact of bronchiectasis on patients with COPD.

Methods: Databases including Embase, PubMed, and the Cochrane Central Register of Controlled Trials were searched comprehensively to identify all relevant human clinical studies published until August 2014. Bronchiectasis was confirmed either by computed tomography or high-resolution computed tomography. One or more clinicopathological or demographical characteristics, including age, sex, smoking history, daily sputum production, exacerbations, inflammatory biomarkers, lung function, and colonization by potentially pathogenic microorganisms (PPMs), were compared between COPD patients with and without bronchiectasis.

Results: Six observational studies with 881 patients were included in the meta-analysis. The mean prevalence of bronchiectasis in patients with COPD was 54.3%, ranging from 25.6% to 69%. Coexistence of bronchiectasis and COPD occurred more often in male patients with longer smoking history. Patients with COPD and comorbid bronchiectasis had greater daily sputum production, more frequent exacerbation, poorer lung function, higher level of inflammatory biomarkers, more chronic colonization by PPMs, and higher rate of Pseudomonas aeruginosa isolation.

Conclusion: In spite of the heterogeneity between included studies and detectable publication bias, this meta-analysis demonstrated the impact of bronchiectasis in patients with COPD in all directions, indicating that coexistence of bronchiectasis should be considered a pathological phenotype of COPD, which may have a predictive value.

No MeSH data available.


Related in: MedlinePlus

Forest plot of mean difference of CRP in COPD patients with and without bronchiectasis.Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; IV, inverse variance; SD, standard deviation.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4524532&req=5

f9-copd-10-1465: Forest plot of mean difference of CRP in COPD patients with and without bronchiectasis.Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; IV, inverse variance; SD, standard deviation.

Mentions: CRP level was higher in COPD patients with bronchiectasis compared with those without bronchiectasis (WMD: 6.11; 95% CI: 0.26 to 11.95; P=0.04; Figure 9). However, a significant publication bias was detectable by funnel plots (Figure S8). Albumin level was lower in COPD patients with bronchiectasis compared with those without the same (WMD: −0.14; 95% CI: −0.23 to −0.06; P=0.001; Figure 10), and no publication bias was observed (Figure S9).


Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis.

Ni Y, Shi G, Yu Y, Hao J, Chen T, Song H - Int J Chron Obstruct Pulmon Dis (2015)

Forest plot of mean difference of CRP in COPD patients with and without bronchiectasis.Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; IV, inverse variance; SD, standard deviation.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4524532&req=5

f9-copd-10-1465: Forest plot of mean difference of CRP in COPD patients with and without bronchiectasis.Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; IV, inverse variance; SD, standard deviation.
Mentions: CRP level was higher in COPD patients with bronchiectasis compared with those without bronchiectasis (WMD: 6.11; 95% CI: 0.26 to 11.95; P=0.04; Figure 9). However, a significant publication bias was detectable by funnel plots (Figure S8). Albumin level was lower in COPD patients with bronchiectasis compared with those without the same (WMD: −0.14; 95% CI: −0.23 to −0.06; P=0.001; Figure 10), and no publication bias was observed (Figure S9).

Bottom Line: Six observational studies with 881 patients were included in the meta-analysis.Coexistence of bronchiectasis and COPD occurred more often in male patients with longer smoking history.Patients with COPD and comorbid bronchiectasis had greater daily sputum production, more frequent exacerbation, poorer lung function, higher level of inflammatory biomarkers, more chronic colonization by PPMs, and higher rate of Pseudomonas aeruginosa isolation.

View Article: PubMed Central - PubMed

Affiliation: Department of Pulmonary Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

ABSTRACT

Background: In the 2014 Global initiative for chronic Obstructive Lung Disease guidelines, bronchiectasis was for the first time defined as a comorbidity of chronic obstructive pulmonary disease (COPD), and this change has been retained in the 2015 update, which emphasizes the influence of bronchiectasis in the natural history of COPD. The present meta-analysis was aimed at summarizing the impact of bronchiectasis on patients with COPD.

Methods: Databases including Embase, PubMed, and the Cochrane Central Register of Controlled Trials were searched comprehensively to identify all relevant human clinical studies published until August 2014. Bronchiectasis was confirmed either by computed tomography or high-resolution computed tomography. One or more clinicopathological or demographical characteristics, including age, sex, smoking history, daily sputum production, exacerbations, inflammatory biomarkers, lung function, and colonization by potentially pathogenic microorganisms (PPMs), were compared between COPD patients with and without bronchiectasis.

Results: Six observational studies with 881 patients were included in the meta-analysis. The mean prevalence of bronchiectasis in patients with COPD was 54.3%, ranging from 25.6% to 69%. Coexistence of bronchiectasis and COPD occurred more often in male patients with longer smoking history. Patients with COPD and comorbid bronchiectasis had greater daily sputum production, more frequent exacerbation, poorer lung function, higher level of inflammatory biomarkers, more chronic colonization by PPMs, and higher rate of Pseudomonas aeruginosa isolation.

Conclusion: In spite of the heterogeneity between included studies and detectable publication bias, this meta-analysis demonstrated the impact of bronchiectasis in patients with COPD in all directions, indicating that coexistence of bronchiectasis should be considered a pathological phenotype of COPD, which may have a predictive value.

No MeSH data available.


Related in: MedlinePlus